Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine

Area of Science:

• Oncology
• Genomics
• Pharmacology

Background:

• Current anticancer drug trials offer population-level validation but clinical success is often limited to specific molecular subtypes.
• Germline and tumor-based aberrations increasingly inform patient response to anticancer therapies.
• Defining molecular contexts is crucial for optimizing anticancer agent efficacy and safety.

Purpose of the Study:

• To provide an overview of molecular determinants influencing anticancer drug response.
• To introduce and define the concept of 'cancer patient profiling'.

Main Methods:

• Review of current literature on molecular determinants in cancer therapy.
• Conceptual framework development for cancer patient profiling.

Main Results:

• Identification of key germline and tumor molecular aberrations impacting drug efficacy.
• Elucidation of the principles and potential of cancer patient profiling.

Conclusions:

• Cancer patient profiling, through system-wide molecular analysis, enables personalized therapy selection.
• This approach aims to maximize therapeutic benefit and minimize toxicity for individual cancer patients.